Matola, Xinavane, Machava and Namaacha, Mozambique
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
Phase
3Span
175 weeksSponsor
Areteia TherapeuticsTeplice
Recruiting
1-1 of 1